The Alba Pérez Foundation has signed a framework collaboration agreement with the Bellvitge Biomedical Research Institute that aims to support research projects related to Ewing's sarcoma, an investigation led by Dr. Òscar Martínez-Tirado, head of IDIBELL’s Sarcomas group. Along the same lines, and making a new step forward, both entities have also signed a specific collaboration contract that is included under this framework contract.
[MEDtalk] How Coming Innovation in Pharmaceutical Industry Can Have an Impact on You as Researcher
Virginia de las Heras
Therapeutical Area, Head of the Immunology, Dermatology, Hepatology and Transplantation Department
New technologies are changing how we perceive the world, how we do things, even how we think. Doing research, drug discovery and development, are experimenting disruptive innovation. Clinical trials as well: new designs, new recruiting procedures, remote monitoring, etc. Pharmaceutical companies are immersed in this deeper transformation.